Esophageal Squamous Cell Carcinoma Patients Have an Increased Risk of Coexisting Colorectal Neoplasms

Overview

Journal Gut Liver

Specialty Gastroenterology

Date 2015 May 13

PMID 25963088

Citations 5

Authors

Myong Ki Baeg

Myung-Gyu Choi

Yun Duk Jung

Sun-Hye Ko

Chul-Hyun Lim

Hyung Hun Kim

Jin Su Kim

Yu Kyung Cho

Jae Myung Park

In Seok Lee

Sang-Woo Kim

Affiliations

Soon will be listed here.

Abstract

Background/aims: Esophageal squamous cell carcinoma (ESCC) and colorectal neoplasms (CRNs) share risk factors. We aimed to investigate whether the CRN risk is increased in ESCC patients.

Methods: ESCC patients who underwent a colonoscopy within 1 year of diagnosis were retrospectively analyzed. Patients were matched 13 by age, gender, and body mass index to asymptomatic controls. CRN was defined as the histological confirmation of adenoma or adenocarcinoma. Advanced CRN was defined as any of the following ≥3 adenomas, high-grade dysplasia, villous features, tumor ≥1 cm, or adenocarcinoma. The risk factors for both CRN and advanced CRN were evaluated by univariate and multivariate analyses.

Results: Sixty ESCC patients were compared with 180 controls. The ESCC group had significantly higher numbers of CRNs (odds ratio [OR], 2.311; 95% confidence interval [CI], 1.265 to 4.220; p=0.006) and advanced CRNs (OR, 2.317; 95% CI, 1.185 to 4.530; p=0.013). Significant risk factors for both CRN and advanced CRN by multivariate analysis included ESCC (OR, 2.157, 95% CI, 1.106 to 4.070, p=0.024; and OR, 2.157, 95% CI, 1.045 to 4.454, p=0.038, respectively) and older age (OR, 1.068, 95% CI, 1.032 to 1.106, p<0.001; and OR, 1.065, 95% CI, 1.024 to 1.109, p=0.002, respectively).

Conclusions: The rates of CRN and advanced CRN are significantly increased in ESCC. Colonoscopy should be considered at ESCC diagnosis.

Citing Articles

Curative-Intended Management of Synchronous Esophageal and Rectal Cancer-A Systematic Literature Review.

Wurschi G, Schneider C, Ernst T, Helfritzsch H, Nowatschin J, Bitter T J Gastrointest Cancer. 2025; 56(1):41.

PMID: 39800833 PMC: 11725541. DOI: 10.1007/s12029-025-01170-7.

Pathological Insights: Enhanced Vision Transformers for the Early Detection of Colorectal Cancer.

Ayana G, Barki H, Choe S Cancers (Basel). 2024; 16(7).

PMID: 38611117 PMC: 11010958. DOI: 10.3390/cancers16071441.

Isolated Colonic Metastasis From Esophageal Adenocarcinoma.

Alshati A, Khosla M, Niu H, Kachaamy T ACG Case Rep J. 2019; 6(3):1-3.

PMID: 31620502 PMC: 6658030. DOI: 10.14309/crj.0000000000000043.

Can Opium Use Contribute to a Higher Risk of Colorectal Cancers? A Matched Case-control Study in Iran.

Naghibzadeh-Tahami A, Yazdi Feyzabadi V, Khanjani N, Ashrafi-Asgarabad A, Alizaeh H, Borhaninejad V Iran J Public Health. 2016; 45(10):1322-1331.

PMID: 27957439 PMC: 5149496.

Importance of colonoscopy in patients undergoing endoscopic resection for superficial esophageal squamous cell carcinoma.

Tominaga K, Doyama H, Nakanishi H, Yoshida N, Takeda Y, Ota R Ann Gastroenterol. 2016; 29(3):318-24.

PMID: 27366032 PMC: 4923817. DOI: 10.20524/aog.2016.0025.

References

Anderson J, Alpern Z, Sethi G, Messina C, Martin C, Hubbard P . Prevalence and risk of colorectal neoplasia in consumers of alcohol in a screening population. Am J Gastroenterol. 2005; 100(9):2049-55. DOI: 10.1111/j.1572-0241.2005.41832.x. View

Natsugoe S, Matsumoto M, Okumura H, Ishigami S, Uenosono Y, Owaki T . Multiple primary carcinomas with esophageal squamous cell cancer: clinicopathologic outcome. World J Surg. 2004; 29(1):46-9. DOI: 10.1007/s00268-004-7525-y. View

Siersema P, Yu S, Sahbaie P, Steyerberg E, Simpson P, Kuipers E . Colorectal neoplasia in veterans is associated with Barrett's esophagus but not with proton-pump inhibitor or aspirin/NSAID use. Gastrointest Endosc. 2006; 63(4):581-6. DOI: 10.1016/j.gie.2005.08.043. View

Kamangar F, Dores G, Anderson W . Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006; 24(14):2137-50. DOI: 10.1200/JCO.2005.05.2308. View

Liu J, Jamieson G, Wu T, Zhang S, Wang Q, Drew P . Cyclooxygenase-2 expression in squamous cell carcinoma of the esophagus. Dis Esophagus. 2006; 19(5):350-4. DOI: 10.1111/j.1442-2050.2006.00594.x. View

Fong S, Dietzsch E, Fong K, Hollosi P, Asuncion L, He Q . Lysyl oxidase-like 2 expression is increased in colon and esophageal tumors and associated with less differentiated colon tumors. Genes Chromosomes Cancer. 2007; 46(7):644-55. DOI: 10.1002/gcc.20444. View

Chuang S, Hashibe M, Scelo G, Brewster D, Pukkala E, Friis S . Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries. Cancer Epidemiol Biomarkers Prev. 2008; 17(6):1543-9. DOI: 10.1158/1055-9965.EPI-07-2876. View

Pech O, Behrens A, May A, Nachbar L, Gossner L, Rabenstein T . Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut. 2008; 57(9):1200-6. DOI: 10.1136/gut.2007.142539. View

Lyronis I, Baritaki S, Bizakis I, Krambovitis E, Spandidos D . K-ras mutation, HPV infection and smoking or alcohol abuse positively correlate with esophageal squamous carcinoma. Pathol Oncol Res. 2008; 14(3):267-73. DOI: 10.1007/s12253-008-9032-1. View

10.

Bollschweiler E, Schloesser T, Leers J, Vallbohmer D, Schafer H, Holscher A . High prevalence of colonic polyps in white males with esophageal adenocarcinoma. Dis Colon Rectum. 2009; 52(2):299-304. DOI: 10.1007/DCR.0b013e318197d06f. View

11.

Siddiqui A, Nazario H, Mahgoub A, Pandove S, Cipher D, Spechler S . The long-term use of statins is associated with a decreased incidence of adenomatous colon polyps. Digestion. 2009; 79(1):17-22. DOI: 10.1159/000203636. View

12.

Rice T, Blackstone E, Rusch V . 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol. 2010; 17(7):1721-4. DOI: 10.1245/s10434-010-1024-1. View

13.

Hong S, Kim J, Choe W, Han H, Sung I, Park H . Prevalence and risk of colorectal neoplasms in asymptomatic, average-risk screenees 40 to 49 years of age. Gastrointest Endosc. 2010; 72(3):480-9. DOI: 10.1016/j.gie.2010.06.022. View

14.

Jemal A, Siegel R, Xu J, Ward E . Cancer statistics, 2010. CA Cancer J Clin. 2010; 60(5):277-300. DOI: 10.3322/caac.20073. View

15.

Stein B, Anderson J, Rajapakse R, Alpern Z, Messina C, Walker G . Body mass index as a predictor of colorectal neoplasia in ethnically diverse screening population. Dig Dis Sci. 2010; 55(10):2945-52. DOI: 10.1007/s10620-009-1113-9. View

16.

Kolligs F, Crispin A, Munte A, Wagner A, Mansmann U, Goke B . Risk of advanced colorectal neoplasia according to age and gender. PLoS One. 2011; 6(5):e20076. PMC: 3101231. DOI: 10.1371/journal.pone.0020076. View

17.

Diamond S, Enestvedt B, Jiang Z, Holub J, Gupta M, Lieberman D . Adenoma detection rate increases with each decade of life after 50 years of age. Gastrointest Endosc. 2011; 74(1):135-40. PMC: 3878149. DOI: 10.1016/j.gie.2011.03.1178. View

18.

Watson A, Collins P . Colon cancer: a civilization disorder. Dig Dis. 2011; 29(2):222-8. DOI: 10.1159/000323926. View

19.

Sun L, Yu S . Meta-analysis: non-steroidal anti-inflammatory drug use and the risk of esophageal squamous cell carcinoma. Dis Esophagus. 2011; 24(8):544-9. DOI: 10.1111/j.1442-2050.2011.01198.x. View

20.

Zauber A, Winawer S, OBrien M, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey B . Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012; 366(8):687-96. PMC: 3322371. DOI: 10.1056/NEJMoa1100370. View